neuroloop at the LSI USA Conference:
Innovation, Networking and Internationale Visibility

Dana Point, USA – Participation in the highly regarded LSI USA Conference in Dana Point provided neuroloop with an excellent platform to present its technology to an international expert audience and engage with key players in the global medtech industry.

March 16-20, 2026 – A particular highlight of the event was the presentation by CEO Dr. Esther Novosel, who introduced neuroloop and its innovative approach to highly selective vagus nerve stimulation (VNS) on the conference stage. Addressing investors, strategists, and industry experts, she highlighted the technology’s potential to improve the lives of patients with chronic conditions, particularly in areas where conventional drug therapies reach their limits.

In addition to expert discussions and insights into the latest developments in medical technology, international networking was a key focus of the conference. The event provided numerous opportunities to strengthen existing partnerships and establish new connections. Such personal interactions are a vital driver of innovation and the advancement of forward-looking healthcare solutions.
“Direct exchange with international experts, investors, and companies is a crucial building block for advancing innovative therapies and maximizing their global impact,” was the conclusion reached by the neuroloop team.

neuroloop would like to thank Kelly Williams and the entire LSI team for organizing a high-caliber event that brings together the international medtech community and fosters dialogue on the future of healthcare.

Press contact
neuroloop GmbH
Breisacher Straße 86, 79110 Freiburg, Germany
E-mail: info@neuroloop.de